Fellous A - Search Results

1

Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice.

Veitia R, Bissery MC, Martinez C, Fellous A. Veitia R, et al. Among authors: fellous a. Br J Cancer. 1998 Oct;78(7):871-7. doi: 10.1038/bjc.1998.595. Br J Cancer. 1998. PMID: 9764577 Free PMC article.

2

Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxel.

Fromes Y, Gounon P, Veitia R, Bissery MC, Fellous A. Fromes Y, et al. Among authors: fellous a. J Protein Chem. 1996 May;15(4):377-88. doi: 10.1007/BF01886864. J Protein Chem. 1996. PMID: 8819014

3

Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel.

Veitia R, David S, Barbier P, Vantard M, Gounon P, Bissery MC, Fellous A. Veitia R, et al. Among authors: fellous a. Br J Cancer. 2000 Aug;83(4):544-9. doi: 10.1054/bjoc.2000.1294. Br J Cancer. 2000. PMID: 10945505 Free PMC article.

4

Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study.

Bernard-Marty C, Treilleux I, Dumontet C, Cardoso F, Fellous A, Gancberg D, Bissery MC, Paesmans M, Larsimont D, Piccart MJ, Di Leo A. Bernard-Marty C, et al. Among authors: fellous a. Clin Breast Cancer. 2002 Dec;3(5):341-5. doi: 10.3816/CBC.2002.n.037. Clin Breast Cancer. 2002. PMID: 12533264

5

A novel human gene, encoding a potential membrane protein conserved from yeast to man, is strongly expressed in testis and cancer cell lines.

Veitia RA, Ottolenghi C, Bissery MC, Fellous A. Veitia RA, et al. Among authors: fellous a. Cytogenet Cell Genet. 1999;85(3-4):217-20. doi: 10.1159/000015296. Cytogenet Cell Genet. 1999. PMID: 10449901

6

The genomic structure of c14orf1 is conserved across eukarya.

Ottolenghi C, Daizadeh I, Ju A, Kossida S, Renault G, Jacquet M, Fellous A, Gilbert W, Veitia R. Ottolenghi C, et al. Among authors: fellous a. Mamm Genome. 2000 Sep;11(9):786-8. doi: 10.1007/s003350010148. Mamm Genome. 2000. PMID: 10967139

7

Estramustine resistance correlates with tau over-expression in human prostatic carcinoma cells.

Sangrajrang S, Denoulet P, Millot G, Tatoud R, Podgorniak MP, Tew KD, Calvo F, Fellous A. Sangrajrang S, et al. Among authors: fellous a. Int J Cancer. 1998 Aug 12;77(4):626-31. doi: 10.1002/(sici)1097-0215(19980812)77:4<626::aid-ijc24>3.0.co;2-2. Int J Cancer. 1998. PMID: 9679768

8

Different microtubule network alterations induced by pachymatismin, a new marine glycoprotein, on two prostatic cell lines.

Sangrajrang S, Zidane M, Berda P, Moré MT, Calvo F, Fellous A. Sangrajrang S, et al. Among authors: fellous a. Cancer Chemother Pharmacol. 2000;45(2):120-6. doi: 10.1007/s002800050019. Cancer Chemother Pharmacol. 2000. PMID: 10663626

9

Estramustine resistance.

Sangrajrang S, Calvo F, Fellous A. Sangrajrang S, et al. Among authors: fellous a. Gen Pharmacol. 1999 Aug;33(2):107-13. doi: 10.1016/s0306-3623(98)00272-9. Gen Pharmacol. 1999. PMID: 10461848 Review.

10

Effects of fluoro-doxorubicin (ME2303) on microtubules: influence of different classes of microtubule-associated proteins.

Fromes Y, Gounon P, Tapiero H, Fellous A. Fromes Y, et al. Among authors: fellous a. J Protein Chem. 1996 Aug;15(6):561-73. doi: 10.1007/BF01908538. J Protein Chem. 1996. PMID: 8895103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters